Login
Toggle navigation
Videos
Categories
Trending
investing in Miami with his new incubator Pareto|Jon Oringer,Co-Founder,Shutterstock
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Founder & Executive Chairman at Shutterstock.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Good things happen when you partner with good people|CHRIS COLLINS,Co Chief Executive Officer,Kelso & Company
00:10:00
Strategic Financing and Exploration Plans: A Conversation with North Isle Copper and Gold
00:10:00
Class Limited (ASX: CL1) CEO and MD Andrew Russell | Michael Chasen, CEO, Class Ltd CL1:ASX
00:10:00
Is Higher Inflation on the Horizon? Insights from Max Monk and Ryan Martin of Johnson Investment Counsel
00:10:00
Welcome Message from H.E. Akylbek Kamaldinov, Kazakhstan's Ambassador to Canada
00:10:00
Keystone Law Group PLC: Full-Year Results | James Knight - Chief Executive Officer of Keystone Law.
00:10:00
From Oil to Renewables: A Company's Sustainable Transformation and Ambitious Investment Plans| Luca Bettonte, CEO,ERG SPA.
00:10:00
Q3 2014 Market Update: Navigating Volatility and Economic Resilience
00:10:00
Valuing Our Veterans: How Amy Bennett and Katie Milazzo Brought Their Skills to T. Rowe Price
00:00:00
Respiri talks Access Telehealth acquisition and US growth - Marjan Mikel Chief Executive Officer, Respiri Ltd
00:10:00
Susan Senecal on the Benefits of Restaurants Canada Membership for A&W | Susan Senecal, President , A&W Revenue Royalties Income Fund.
00:10:00
Understanding the Dynamics of Financial Regulation in Emerging Markets |Brandon White, Managing Director, Charlesbank Capital Partners.